铂-话题@MedSci

#铂#

382篇内容 | 6071人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737598, encodeId=c7441e3759878, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=和铂医药任命Atul Deshpande博士为首席战略官兼美国运营负责人, objectType=article, longId=157427, objectId=d7fb15e427d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7fb15e427d7, replyNumber=0, likeNumber=58, createdTime=2019-05-04, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7fb15e427d7, moduleTitle=和铂医药任命Atul Deshpande博士为首席战略官兼美国运营负责人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7fb15e427d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737618, encodeId=0f071e3761822, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Nat Commun：GSTA4在能够减少铂耳毒性, objectType=article, longId=180186, objectId=5ecc1801861a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ecc1801861a, replyNumber=0, likeNumber=72, createdTime=2019-10-08, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ecc1801861a, moduleTitle=Nat Commun：GSTA4在能够减少铂耳毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ecc1801861a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737615, encodeId=bb3a1e3761506, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Gastroen Hepatol：奥沙利铂辅助温热腹腔内化疗与结肠癌患者转移风险, objectType=article, longId=176643, objectId=be451e6643f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be451e6643f4, replyNumber=0, likeNumber=67, createdTime=2019-10-11, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be451e6643f4, moduleTitle=Lancet Gastroen Hepatol：奥沙利铂辅助温热腹腔内化疗与结肠癌患者转移风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be451e6643f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737606, encodeId=254e1e376065b, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=卵巢癌术后铂-紫杉醇腹腔内给药生存获益优于静脉给药, objectType=article, longId=164705, objectId=2fc1164e0599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fc1164e0599, replyNumber=0, likeNumber=54, createdTime=2019-05-05, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fc1164e0599, moduleTitle=卵巢癌术后铂-紫杉醇腹腔内给药生存获益优于静脉给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fc1164e0599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737592, encodeId=4c151e3759253, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Pediatr Blood Cancer：在顺铂治疗后的儿童癌症幸存者中，不对称感官听力损失是晚发听力损失的风险因子, objectType=article, longId=152351, objectId=e91d1523517d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e91d1523517d, replyNumber=0, likeNumber=80, createdTime=2019-02-16, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e91d1523517d, moduleTitle=Pediatr Blood Cancer：在顺铂治疗后的儿童癌症幸存者中，不对称感官听力损失是晚发听力损失的风险因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e91d1523517d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737610, encodeId=6c401e3761094, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=奥氮平5mg联合标准止吐方案或可作为预防顺铂所致恶心呕吐的新型止吐方案, objectType=article, longId=167921, objectId=772e16e92199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=772e16e92199, replyNumber=0, likeNumber=63, createdTime=2019-08-24, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=772e16e92199, moduleTitle=奥氮平5mg联合标准止吐方案或可作为预防顺铂所致恶心呕吐的新型止吐方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=772e16e92199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737608, encodeId=242d1e37608a7, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Exp Clin Cancer Res：顺铂耐药肺癌细胞通过Src / CD155 / MIF功能途径促进肿瘤相关巨噬细胞的M2极化, objectType=article, longId=165304, objectId=95f2165304b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95f2165304b9, replyNumber=0, likeNumber=67, createdTime=2019-10-29, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95f2165304b9, moduleTitle=J Exp Clin Cancer Res：顺铂耐药肺癌细胞通过Src / CD155 / MIF功能途径促进肿瘤相关巨噬细胞的M2极化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95f2165304b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737597, encodeId=620c1e375972f, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：三阴性乳腺癌患者新辅助卡铂联合多西紫杉醇治疗后病情缓解情况及预后, objectType=article, longId=155771, objectId=2def155e7198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2def155e7198, replyNumber=0, likeNumber=65, createdTime=2019-11-07, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2def155e7198, moduleTitle=CLIN CANCER RES：三阴性乳腺癌患者新辅助卡铂联合多西紫杉醇治疗后病情缓解情况及预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2def155e7198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737601, encodeId=79a71e376010f, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：Veliparib联合卡铂和依托泊苷治疗非小细胞肺癌和其它实体肿瘤, objectType=article, longId=159009, objectId=1690159009ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1690159009ef, replyNumber=0, likeNumber=89, createdTime=2019-11-08, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1690159009ef, moduleTitle=CLIN CANCER RES：Veliparib联合卡铂和依托泊苷治疗非小细胞肺癌和其它实体肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1690159009ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737604, encodeId=dc461e3760470, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J clin oncol:ASCO临床实践指南：Ⅲ期结肠癌含奥沙利铂辅助化疗，3个月 or 6个月？, objectType=article, longId=164617, objectId=938c16461e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=938c16461e8e, replyNumber=0, likeNumber=68, createdTime=2019-12-01, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=938c16461e8e, moduleTitle=J clin oncol:ASCO临床实践指南：Ⅲ期结肠癌含奥沙利铂辅助化疗，3个月 or 6个月？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=938c16461e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737584, encodeId=b96d1e37584dd, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Pediatr Hematol Oncol：实体肿瘤儿童中，顺铂诱导的耳毒性研究, objectType=article, longId=146707, objectId=8cb3146e0761, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cb3146e0761, replyNumber=0, likeNumber=63, createdTime=2019-02-28, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cb3146e0761, moduleTitle=J Pediatr Hematol Oncol：实体肿瘤儿童中，顺铂诱导的耳毒性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cb3146e0761)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737594, encodeId=85dc1e37594b0, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet：西妥昔单抗vs顺铂治疗HPV阳性口咽鳞状细胞癌, objectType=article, longId=153668, objectId=0cec153668c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cec153668c0, replyNumber=0, likeNumber=63, createdTime=2019-01-09, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cec153668c0, moduleTitle=Lancet：西妥昔单抗vs顺铂治疗HPV阳性口咽鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cec153668c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737599, encodeId=026b1e3759944, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：卡铂和紫杉醇对未知原发癌患者的部位特异性治疗：II期临床试验, objectType=article, longId=158471, objectId=e6371584e194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6371584e194, replyNumber=0, likeNumber=87, createdTime=2019-12-19, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6371584e194, moduleTitle=JCO：卡铂和紫杉醇对未知原发癌患者的部位特异性治疗：II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6371584e194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737580, encodeId=41f31e3758047, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Natl Cancer Inst：TNBC：新辅助蛋白结合型紫杉醇+卡铂vs蛋白结合型紫杉醇+吉西他滨, objectType=article, longId=144214, objectId=35ae14421406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35ae14421406, replyNumber=0, likeNumber=84, createdTime=2019-03-28, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35ae14421406, moduleTitle=J Natl Cancer Inst：TNBC：新辅助蛋白结合型紫杉醇+卡铂vs蛋白结合型紫杉醇+吉西他滨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35ae14421406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737587, encodeId=e4401e3758708, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：顺铂耐药的卵巢癌中存在有丝分裂退出异常, objectType=article, longId=150111, objectId=bdf715011151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdf715011151, replyNumber=0, likeNumber=72, createdTime=2018-12-31, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdf715011151, moduleTitle=CLIN CANCER RES：顺铂耐药的卵巢癌中存在有丝分裂退出异常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdf715011151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737595, encodeId=05d51e37595f3, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：Binimetinib联合紫杉醇治疗铂类耐药卵巢癌, objectType=article, longId=154015, objectId=f65015401548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f65015401548, replyNumber=0, likeNumber=66, createdTime=2019-04-23, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f65015401548, moduleTitle=CLIN CANCER RES：Binimetinib联合紫杉醇治疗铂类耐药卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f65015401548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737600, encodeId=95a41e37600de, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：Patritumab联合西妥昔单抗和铂类治疗头颈部鳞状细胞癌, objectType=article, longId=159008, objectId=21e215900857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21e215900857, replyNumber=0, likeNumber=68, createdTime=2019-02-21, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21e215900857, moduleTitle=CLIN CANCER RES：Patritumab联合西妥昔单抗和铂类治疗头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21e215900857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737593, encodeId=82181e37593c9, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet：西妥昔单抗vs顺铂用于HPV阳性口腔癌, objectType=article, longId=153667, objectId=f0c515366e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0c515366e77, replyNumber=0, likeNumber=92, createdTime=2019-10-13, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0c515366e77, moduleTitle=Lancet：西妥昔单抗vs顺铂用于HPV阳性口腔癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0c515366e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737582, encodeId=65021e37582f0, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性, objectType=article, longId=145876, objectId=88e41458e6ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88e41458e6ed, replyNumber=0, likeNumber=74, createdTime=2019-06-21, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88e41458e6ed, moduleTitle=lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88e41458e6ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737596, encodeId=eeb31e37596da, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Cutan Ocul Toxicol：碧萝芷对顺铂诱导的视神经损伤实验研究, objectType=article, longId=154353, objectId=e8b61543538f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8b61543538f, replyNumber=0, likeNumber=65, createdTime=2019-10-21, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8b61543538f, moduleTitle=Cutan Ocul Toxicol：碧萝芷对顺铂诱导的视神经损伤实验研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8b61543538f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂

2020-05-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

和铂医药任命Atul Deshpande博士为首席战略官兼美国运营负责人

2019-05-04

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Nat Commun：GSTA4在能够减少铂耳毒性

2019-10-08

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Gastroen Hepatol：奥沙利铂辅助温热腹腔内化疗与结肠癌患者转移风险

2019-10-11

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

卵巢癌术后铂-紫杉醇腹腔内给药生存获益优于静脉给药

2019-05-05

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Pediatr Blood Cancer：在顺铂治疗后的儿童癌症幸存者中，不对称感官听力损失是晚发听力损失的风险因子

2019-02-16

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

奥氮平5mg联合标准止吐方案或可作为预防顺铂所致恶心呕吐的新型止吐方案

2019-08-24

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Exp Clin Cancer Res：顺铂耐药肺癌细胞通过Src / CD155 / MIF功能途径促进肿瘤相关巨噬细胞的M2极化

2019-10-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：三阴性乳腺癌患者新辅助卡铂联合多西紫杉醇治疗后病情缓解情况及预后

2019-11-07

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：Veliparib联合卡铂和依托泊苷治疗非小细胞肺癌和其它实体肿瘤

2019-11-08

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J clin oncol:ASCO临床实践指南：Ⅲ期结肠癌含奥沙利铂辅助化疗，3个月 or 6个月？

2019-12-01

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Pediatr Hematol Oncol：实体肿瘤儿童中，顺铂诱导的耳毒性研究

2019-02-28

智智灵药 (审核中...)

前往app查看评论内容

#铂#

Lancet：西妥昔单抗vs顺铂治疗HPV阳性口咽鳞状细胞癌

2019-01-09

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：卡铂和紫杉醇对未知原发癌患者的部位特异性治疗：II期临床试验

2019-12-19

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Natl Cancer Inst：TNBC：新辅助蛋白结合型紫杉醇+卡铂vs蛋白结合型紫杉醇+吉西他滨

2019-03-28

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：顺铂耐药的卵巢癌中存在有丝分裂退出异常

2018-12-31

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：Binimetinib联合紫杉醇治疗铂类耐药卵巢癌

2019-04-23

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：Patritumab联合西妥昔单抗和铂类治疗头颈部鳞状细胞癌

2019-02-21

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet：西妥昔单抗vs顺铂用于HPV阳性口腔癌

2019-10-13

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性

2019-06-21

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Cutan Ocul Toxicol：碧萝芷对顺铂诱导的视神经损伤实验研究

2019-10-21

科室
- - 订阅+
  - 更多科室
工具
服务